LifeLens Technologies, Inc.
PrivateLast Round
Early Stage
VC
Sep 8, 2026
Total Funding Raised
$42.65M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
LifeLens Technologies, Inc. is a healthtech company that develops wearable physiologic monitoring devices and AI-driven analytics for real-time remote patient monitoring.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Defense Tech, Health IoT, Sensors, Medical AI
Business Model
B2G
Customer Profile
Government Contracts, Hardware Sales, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LifeLens Technologies, Inc. Comparables
Compare LifeLens Technologies, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sempulse | 86% | |
| Equivital | 82% | |
| Sibel Health | 82% |
LifeLens Technologies, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Stage VC | Sep 8, 2026 | ||||
| Early Funding | Nov 4, 2025 | ||||
| Early Funding | Jul 15, 2024 | ||||
| Series A | Oct 15, 2021 | ||||
| Seed | Jul 20, 2020 | ||||
Debt | Jul 17, 2019 |
LifeLens Technologies, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Paragon Equity Partners | Series A, Early Funding |
| Valiance Asset Management | Early Funding |
| Brightstone Venture Capital | Early Funding |
| Highcroft Capital | Early Funding |
| Medical Technology Enterprise Consortium | Grant |
| Next Chapter Ventures | Seed, Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 8, 2026
$21M raised in early stage VC round.
- Aug 21, 2026
Monthly visitors increased 33% MoM, reaching 2.8K.
LifeLens Technologies, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about LifeLens Technologies, Inc.'s valuation, stock price, and market status.
Is LifeLens Technologies, Inc. a public or private company?
LifeLens Technologies, Inc. is a private company.
What is the current stock price of LifeLens Technologies, Inc.?
LifeLens Technologies, Inc. is a private company with no public stock price. Caplight tracks LifeLens Technologies, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is LifeLens Technologies, Inc. worth (valuation)?
Valuation information for LifeLens Technologies, Inc. is not publicly available.
Can I buy LifeLens Technologies, Inc. stock?
LifeLens Technologies, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was LifeLens Technologies, Inc.'s last funding round?
LifeLens Technologies, Inc.'s most recent funding round was Early Stage VC on September 8, 2026.
Who are the main investors in LifeLens Technologies, Inc.?
Key investors in LifeLens Technologies, Inc. include Paragon Equity Partners, Valiance Asset Management, Brightstone Venture Capital, Highcroft Capital, Medical Technology Enterprise Consortium.
Will LifeLens Technologies, Inc. IPO soon?
No public IPO plans have been announced for LifeLens Technologies, Inc..
How can I track LifeLens Technologies, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor LifeLens Technologies, Inc.'s secondary market activity and sign up for updates.